will focus on the role of vitamin K in the calcification process in dialysis patients. Animal experiments and indirect clinical evidence of a protective effect of vitamin K were the rationale for the VitaVask [...] VitaVask study, in which hemodialysis patients were randomly treated with vitamin K1. PD Dr. Saritas from the University Hospital Aachen is an expert in the field and was significantly involved in the VitaVask [...] forward to hearing what Dr. Saritas will tell us about the pathophysiological significance of the vitamin K balance in patients with kidney disease and what consequences the current study results will have for

OR in building K05 on the 4th level in block 1 . Directions for relatives: You enter the MHH through the main entrance (building K06) and walk through the Ladenstraße to the elevator node_A . There, turn [...] MHH through the main entrance (building K06) and walk through the Ladenstraße to the elevator node_A . There, turn right until you reach elevator node D (building K05) . Take the passenger elevator to floor [...] turn right to the level of elevator node D (building K05) . Take the passenger elevator to floor 4 and turn right after exiting. There is a telephone on the glass door to your Legal. You can reach the head

Papantonopoulou O, Hardt A, Aschenbrenner A, Kreer C, Quast T, Xu A, Schmidleithner L, Theis H, Do T, Sumatoh H, Lauterbach M, Schulte-Schrepping J, Günther P, Xue J, Baßler K, Ulas T, Klee K, Katzmarski N, Herresthal [...] McCurry K, Wang IW, Deuse T, Lesèche G, Thomas P, Tudorache I, Kühn C, Avsar M, Wiegmann B, Sommer W, Neyrinck A, Schiavon M, Calabrese F, Santelmo N, Olland A, Falcoz PE, Simon AR, Varela A, Madsen JC [...] JC, Hertz M, Haverich A, Ardehali A. Normothermic ex-vivo preservation with the portable Organ Care System Lung device for bilateral lung transplantation (INSPIRE): a randomized, open-label, non-inferiority

B, Ganser A, Franzke A: Inflammatory pseudotumor of the lung following invasive aspergillosis in a patient with chronic graft-vs.-host disease. Eur J Haematol 2005; 75(1): 68-72 Schwarz A, Gwinner W, [...] overexpression in a patient with chronic myeloid leukemia treated with imatinib. Cancer Genet Cytogenet 2005; 159(2): 164-7 Germeshausen M, Schulze H, Kratz C, Wilkens L, Repp R, Shannon K, Welte K, Ballmaier [...] Ganser A, Aivado M, Heinsch M, Aul C: Treatment of myelodysplastic syndrome with isolated del(5q) including bands q31-q33 with a combination of all-trans-retinoic acid and tocopherol-alpha: a phase II

and Palliative Care Indicators Tool (SPICT-DE). GMS Ger Med Sci. 2020; 18: Doc02 Afshar K, Feichtner A, Boyd K et al. Systematic development and adjustment of the German version of the Supportive and [...] the integration of palliative care into the daily routine of general practitioners is a challenge. There is therefore a need for more in-depth research into how the implementation of palliative care by GPs [...] 17: 27 (PubMed) Afshar K, Müller-Mundt G, Schneider N. How can patients with chronic progressive non-oncological diseases be identified for whom palliative care is appropriate? A pilot study to test the

9: 241-246 Grotkamp S, Cibis W, Bahemann A, Baldus A, Behrens J, Nyffeler ID, Echterhoff W, Fialka-Moser V, Fries W, Fuchs H, Gmünder HP, Gutenbrunner C, Keller K, Nüchtern E, Pöthig D, Queri S, Rentsch [...] Germany: A critical overview. Phys Med Rehab Kuror 2014; 24: 173-182 Meyer T, Gutenbrunner C, Kiekens C, Skempes D, Melvin JL, Schedler K, Imamura M, Stucki G.ISPRM discussion paper: Proposing a conceptual [...] pain and physical functioning: a longitudinal mediator analysis. DRV Publications 2014; 103: 502-504 Briest J, Egen C, Kahl K, Tegtbur U, Born M, Fuhr H, Brinkmeier U, Höpner K, Korallus C, Gutenbrunner C:

Ankerst D, Renders L, Novotny A, Hartmann D, Jell A, Rahmel A, Wahba R, Mühlfeld A, Bouts A, Ysebaert D, Globke B, Jacobs-Tulleneers-Thevissen D, Piros L, Stippel D, Heller K, Eisenberger U, van Laecke S [...] Ruzzenente A, Kingham TP, Scatton O, Liu R, Mejia A, Mishima K, Wakabayashi G, Lopez-Ben S, Wang X, Ferrero A, Ettorre GM, Vivarelli M, Mazzaferro V, Giuliante F, Yong CC, Yin M, Monden K, Geller D, Chen [...] Vogel A, Falk CS, Schambach A, Gerovska D, Araúzo-Bravo MJ, Vondran FWR , Cantz T, Horscroft N, Balakrishnan A, Chevessier F, Ott M, Sharma AD. Therapeutic HNF4A mRNA attenuates liver fibrosis in a preclinical

Hierundar A, Knochel K, Münch U, Neitzke G, Nydahl P, Rogge A (2021) Intensivmedizin: Besuche fördern die Genesung , in: Dtsch Arztebl 2021; 118 (45): A 2112-4 September 2021: Selter, F., Persson, K., Risse [...] r#/10.1055-a-1205-0672 Print Short version: Gesundheitswesen 2020; 82 (11): 852-853. DOI 10.1055/a-1205-0672 January 2020 Persson K, Selter F, Neitzke G, Kunzmann P (2020) "Philosophy of a "Good Death" [...] Working Group. March 2022: Erdmann A, Spoden C, Hirschberg I, Neitzke G (2022). Talking about the end of life: communication patterns in amyotrophic lateral sclerosis - a scoping review. Palliative Care and

r. 1, 30625 Hannover, Germany H. Jürgens a, R. Kabuß a, T. Plumbaum a, B. Weigel a, G. Kretzmer a, K. Schügerl a*, K. Andres b, E. Ignatzek b, F. Giffhorn c, a Institute for Technical Chemistry, University [...] Publications Kabuß R. , Ashikov A., Oelmann S., Gerardy-Schahn R.*, and Bakker H ., (2005), ER retention of the large splice variant of the UDP-galactose transporter is caused by a di-lysine motif, Glycobiology

31278348; PMCID: PMC6611798. Kapanadze T, Bankstahl JP, Wittneben A, Koestner W, Ballmaier M, Gamrekelashvili J, Krishnasamy K, Limbourg A, Ross TL, Meyer GJ, Haller H, Bengel FM, Limbourg FP. Multimodal [...] Briseño CG, Ramasamy SK, Krishnasamy K, Limbourg A, Kapanadze T, Ishifune C, Hinkel R, Radtke F, Strobl LJ, Zimber-Strobl U, Napp LC, Bauersachs J, Haller H, Yasutomo K, Kupatt C, Murphy KM, Adams RH, Weber [...] organs. This work has opened a new aspect of the concept of endothelial dysfunction and revealed another important function of blood vessels independent of blood flow. In a current clinical trial of the